Published in Breast Cancer Res Treat on April 01, 2006
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65
Guideline for the management of breast lumps. Can J Surg (1998) 4.02
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol (1998) 2.42
Cancer in an ileoanal reservoir: a new late complication? Gut (1990) 2.41
Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism (2000) 2.30
Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet (1998) 2.12
A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ (2001) 2.11
Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet (1986) 2.06
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol (1999) 2.02
An unusual intraoperative complication of stapled colorectal anastomosis: report of a case and review of the literature. Can J Surg (1993) 2.00
Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol (1999) 1.92
Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis (1986) 1.91
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology (1995) 1.90
Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum (1996) 1.82
Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology (1994) 1.66
The ileal reservoir and ileoanal anastomosis procedure. Factors affecting technical and functional outcome. Dis Colon Rectum (1988) 1.64
Adjuvant interferon therapy for patients at high risk for recurrent melanoma: an updated systematic review and practice guideline. Clin Oncol (R Coll Radiol) (2012) 1.62
Revising the troublesome stoma: combined abdominal wall recontouring and revision of stomas. Dis Colon Rectum (2003) 1.58
Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology (1991) 1.57
Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making (2000) 1.51
Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum (2002) 1.50
Functional outcome of conversion of ileorectal anastomosis to ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum (1999) 1.49
The pelvic pouch and ileoanal anastomosis procedure. Surgical technique and initial results. Am J Surg (1985) 1.47
Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum (2000) 1.47
Complications of loop ileostomy. Am J Surg (1987) 1.43
Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol (1999) 1.42
Primary excision margins and sentinel lymph node biopsy in clinically node-negative melanoma of the trunk or extremities. Clin Oncol (R Coll Radiol) (2011) 1.39
Unusual presentation of omphalomesenteric duct remnant: a variant of mesodiverticular band causing intestinal obstruction. J Pediatr Surg (2000) 1.39
Anal wall thickness under normal and inflammatory conditions of the anorectum as determined by endoluminal ultrasonography. Am J Gastroenterol (1995) 1.38
Double stapling technique for low anterior resection. Dis Colon Rectum (1983) 1.38
Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg (2000) 1.35
Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. Gastroenterology (1998) 1.32
Reevaluation of nitrate and nitrite levels in the human intestine. Cancer Res (1981) 1.27
The double stapling technique for low anterior resection of rectal carcinoma. Dis Colon Rectum (1986) 1.27
Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies. Clin Oncol (R Coll Radiol) (2008) 1.26
Risk factors for pelvic pouch failure. Dis Colon Rectum (1997) 1.25
Rare spontaneous regression of patent omphalomesenteric duct after birth. Arch Dis Child Fetal Neonatal Ed (2002) 1.23
Women's views on chemoprevention of breast cancer: qualitative study. Can Fam Physician (2006) 1.21
Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group. Curr Oncol (2008) 1.20
Treatment of rectovaginal fistulas that has failed previous repair attempts. Dis Colon Rectum (1995) 1.18
Preduodenal portal vein causing duodenal obstruction associated with situs inversus, intestinal malrotation, and polysplenia: A case report. J Pediatr Surg (2002) 1.17
Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research. Breast Cancer Res Treat (2013) 1.17
Canine small bowel transplantation. A study of the immunological responses. Arch Surg (1976) 1.16
STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clin Genet (1999) 1.13
Acquisition of metastatic tissue from patients with bone metastases from breast cancer. Breast Cancer Res Treat (2010) 1.12
Sentinel node detection and definition may depend on the imaging agent and timing. Clin Nucl Med (1999) 1.12
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet (1999) 1.10
Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol (2001) 1.08
Biosynthesis of eicosapentaenoic acid in the microalga Porphyridium cruentum. I: The use of externally supplied fatty acids. Lipids (1996) 1.07
Restorative proctocolectomy. Clinical results and manometric findings with long and short rectal cuffs. Dis Colon Rectum (1986) 1.07
Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol (1996) 1.07
Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting. Curr Oncol (2012) 1.06
Long-term results of anterior resection using the double-stapling technique. Dis Colon Rectum (1995) 1.05
Clinical correlates of bacteremia in a Veterans Administration extended care facility. J Am Geriatr Soc (1988) 1.05
Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab (1999) 1.04
Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut (2005) 1.03
S-pouches vs. J-pouches. A comparison of functional outcomes. Dis Colon Rectum (1987) 1.01
Surgical aspects of familial adenomatous polyposis. Int J Colorectal Dis (1988) 1.01
Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Dis Colon Rectum (1988) 1.01
Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut (2001) 0.99
Small bowel transplantation in the dog using cyclosporine. Transplantation (1983) 0.99
Histologic monitoring of rejection in small intestinal transplantation. Transplant Proc (1982) 0.99
Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey. Curr Oncol (2010) 0.99
Results of the pelvic-pouch procedure in patients with Crohn's disease. Dis Colon Rectum (1991) 0.98
Crohn's disease and pregnancy. Dis Colon Rectum (1990) 0.98
The role of neoadjuvant (HER)2-targeted therapies in (HER)2-overexpressing breast cancers. Curr Oncol (2009) 0.98
Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology (2001) 0.97
Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer? Curr Oncol (2012) 0.97
Management of mesenteric desmoid tumours in familial adenomatous polyposis. Can J Surg (1992) 0.96
Small intestinal transplantation using cyclosporine. Report of a case. Transplantation (1986) 0.96
Operative and environmental risk factors for recurrence of Crohn's disease. Int J Colorectal Dis (1999) 0.96
Histopathological features of congenital fundus lesions in familial adenomatous polyposis. Can J Ophthalmol (1990) 0.96
Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis. Dis Colon Rectum (2001) 0.96
Morphologic studies of intestinal allograft rejection. Immunosuppression with cyclosporine. Dis Colon Rectum (1984) 0.96
Prevalence of overt metastases in locally advanced breast cancer. Clin Oncol (R Coll Radiol) (2008) 0.95
Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation (1994) 0.95
Preliminary report on the Mount Sinai Hospital Inflammatory Bowel Disease Genetics Project. Dis Colon Rectum (1997) 0.94
Coping styles, psychopathology and intellectual performance in patients with familial adenomatous polyposis. Gen Hosp Psychiatry (1992) 0.94
Subtotal colectomy for ulcerative colitis: complications related to the rectal remnant. Dis Colon Rectum (1991) 0.94
Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol (1993) 0.94
Unusual presentation of psoas abscess in a child. J Pediatr Surg (2001) 0.93
Management of patients with polyps containing malignancy removed by colonoscopic polypectomy. Dis Colon Rectum (1984) 0.93
Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage. Transplantation (1985) 0.92
Symposium on outpatient anorectal procedures. Alternatives to surgical hemorrhoidectomy. Can J Surg (1985) 0.92
Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects. Schweiz Med Wochenschr (1997) 0.92
Improved results following use of an advancement technique in the treatment of ileoanal anastomotic complications. Int J Colorectal Dis (1988) 0.92
Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines. Dis Colon Rectum (1994) 0.91
Outcome of the pelvic pouch procedure in patients with prior perianal disease. Dis Colon Rectum (1997) 0.91
Familial polyposis and the role of the preventive registry. Can Med Assoc J (1981) 0.91
Effect of colectomy on bile composition, cholesterol crystal formation, and gallstones in patients with ulcerative colitis. Ann Surg (1991) 0.91
Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples. Clin Exp Metastasis (2009) 0.90
Preference weights for chemotherapy side effects from the perspective of women with breast cancer. Breast Cancer Res Treat (2013) 0.90
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer. Breast Cancer Res Treat (2010) 0.90
Anal fistula plug: a prospective evaluation of success, continence and quality of life in the treatment of complex fistulae. Colorectal Dis (2014) 0.90
Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians. Curr Oncol (2011) 0.89
Sulindac for periampullary polyps in FAP patients. Int J Colorectal Dis (1997) 0.89
Tissue plasminogen activator (tPA) inhibits interleukin-1 induced acute lung leak. Free Radic Biol Med (1998) 0.89
Thrombogenicity of total parenteral nutrition solutions: I. Effect on induction of monocyte/macrophage procoagulant activity. Gastroenterology (1989) 0.89